Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Pietra

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
Blood|November 18, 2015
Germline RBBP6 mutations in familial myeloproliferative neoplasmsAshot S Harutyunyan, Roberto Giambruno, Christian Krendl, et al.
Leukemia Research|May 8, 2018
Phenotype variability of patients with post polycythemia vera and post essential thrombocythemia myelofibrosis is associated with the time to progression from polycythemia vera and essential thrombocythemiaBarbara Mora, Toni Giorgino, Paola Guglielmelli, et al.
Cancer Medicine|June 8, 2019
Second primary malignancies in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 2233 patientsBarbara Mora, Elisa Rumi, Paola Guglielmelli, et al.
Blood Cancer Journal|October 7, 2018
Gender effect on phenotype and genotype in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis: results from the MYSEC projectDaniela Barraco, Barbara Mora, Paola Guglielmelli, et al.
Haematologica|April 7, 2018
Value of cytogenetic abnormalities in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study of the MYSEC projectBarbara Mora, Toni Giorgino, Paola Guglielmelli, et al.
Plos One|October 23, 2013
Complex patterns of chromosome 11 aberrations in myeloid malignancies target CBL, MLL, DDB1 and LMO2Thorsten Klampfl, Jelena D Milosevic, Ana Puda, et al.
American Journal of Hematology|August 14, 2012
Clinical significance of genetic aberrations in secondary acute myeloid leukemiaJelena D Milosevic, Ana Puda, Luca Malcovati, et al.
The New England Journal of Medicine|December 12, 2013
Somatic mutations of calreticulin in myeloproliferative neoplasmsThorsten Klampfl, Heinz Gisslinger, Ashot S Harutyunyan, et al.
Blood Advances|March 5, 2021
Gene expression profile correlates with molecular and clinical features in patients with myelofibrosisSebastiano Rontauroli, Sara Castellano, Paola Guglielmelli, et al.
Blood Cancer Discovery|April 11, 2022
Type I but Not Type II Calreticulin Mutations Activate the IRE1α/XBP1 Pathway of the Unfolded Protein Response to Drive Myeloproliferative NeoplasmsJuan Ibarra, Yassmin A Elbanna, Katarzyna Kurylowicz, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Blood|November 18, 2015
Germline RBBP6 mutations in familial myeloproliferative neoplasmsAshot S Harutyunyan, Roberto Giambruno, Christian Krendl, et al.
Leukemia Research|May 8, 2018
Phenotype variability of patients with post polycythemia vera and post essential thrombocythemia myelofibrosis is associated with the time to progression from polycythemia vera and essential thrombocythemiaBarbara Mora, Toni Giorgino, Paola Guglielmelli, et al.
Cancer Medicine|June 8, 2019
Second primary malignancies in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 2233 patientsBarbara Mora, Elisa Rumi, Paola Guglielmelli, et al.
Blood Cancer Journal|October 7, 2018
Gender effect on phenotype and genotype in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis: results from the MYSEC projectDaniela Barraco, Barbara Mora, Paola Guglielmelli, et al.
Haematologica|April 7, 2018
Value of cytogenetic abnormalities in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study of the MYSEC projectBarbara Mora, Toni Giorgino, Paola Guglielmelli, et al.
Plos One|October 23, 2013
Complex patterns of chromosome 11 aberrations in myeloid malignancies target CBL, MLL, DDB1 and LMO2Thorsten Klampfl, Jelena D Milosevic, Ana Puda, et al.
American Journal of Hematology|August 14, 2012
Clinical significance of genetic aberrations in secondary acute myeloid leukemiaJelena D Milosevic, Ana Puda, Luca Malcovati, et al.
The New England Journal of Medicine|December 12, 2013
Somatic mutations of calreticulin in myeloproliferative neoplasmsThorsten Klampfl, Heinz Gisslinger, Ashot S Harutyunyan, et al.
Blood Advances|March 5, 2021
Gene expression profile correlates with molecular and clinical features in patients with myelofibrosisSebastiano Rontauroli, Sara Castellano, Paola Guglielmelli, et al.
Blood Cancer Discovery|April 11, 2022
Type I but Not Type II Calreticulin Mutations Activate the IRE1α/XBP1 Pathway of the Unfolded Protein Response to Drive Myeloproliferative NeoplasmsJuan Ibarra, Yassmin A Elbanna, Katarzyna Kurylowicz, et al.
Pageof 10